Skip to content

Fao Ectad Bamako

Resolab – Rabies Subnetwork

  • Home
  • Antibody Products
  • Bamako Mali
  • Rabies Research
  • Fao Ectad Bamako
  • Toggle search form

Subclinical hypothyroidism is associated with basal ganglia enlarged perivascular spaces and overall cerebral small vessel disease load

Posted on February 10, 2022 By Clayton No Comments on Subclinical hypothyroidism is associated with basal ganglia enlarged perivascular spaces and overall cerebral small vessel disease load
Background: The association between subclinical hypothyroidism (SCH) and cerebral small vessel disease (CSVD) in the stroke-free population is currently unclear.
Methods: A total of 354 individuals without a history of stroke were enrolled in this study. Demographic data, medical history, vascular risk factors, carotid arteriosclerosis, and the results of laboratory tests were collated. SCH is defined as an elevation in thyroid-stimulating hormone levels, but with normal free thyroxine levels. Magnetic resonance imaging (MRI) was used to assess 4 markers of CSVD, including white matter hyperintensities (WMHs), lacunes, deep microbleeds, and enlarged perivascular spaces (EPVSs).
The overall CSVD load was then ranked using an ordinal scale ranging from 0 to 4. Brain atrophy was measured semi-quantitatively on MRI. A binary logistic regression model was used to explore the association of SCH with each CSVD marker after adjusting for confounding factors. The ordinal regression model was used to explore the association of SCH with CSVD burden and brain atrophy after adjusting for confounding factors.
Results: The mean age of the participants (66.9% males) was 69.4±12.8 years. SCH was observed in 44 (12.4%) participants. MRI findings revealed 13% of cases with lacunes, 6.2% with microbleeds, 50.3% with confluent WMH, and 49.2% with extensive basal ganglia EPVS. Assessment of total CSVD burden showed that 29.1% scored 1, 30.5% scored 2, 6.5% scored 3, and 2.3% scored ≥3. SCH was associated with extensive basal ganglia EPVS Gentaur Whatman Filter  [odds ratio (OR) =2.175; 95% confidence interval (CI): 1.075 to 4.401] and total CSVD load (OR =1.879; 95% CI: 1.028 to 3.438). SCH was not associated with advanced brain atrophy.
Conclusions: SCH is associated with the advanced total burden of CSVD and basal ganglia EPVS in the stroke-free population.

Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is an epidemic burden and remains highly prevalent worldwide. The significant mortality rates of HCC are largely due to the tendency of late diagnosis and the multifaceted, complex nature of treatment. Meanwhile, current therapeutic modalities such as liver resection and transplantation are only effective for resolving early-stage HCC. Hence, alternative approaches are required to improve detection and enhance the efficacy of current treatment options.
Nanotheranostic platforms, which utilize biocompatible nanoparticles to perform both diagnostics and targeted delivery, has been considered a potential approach for cancer management in the past few decades. Advancement of nanomaterials and biomedical engineering techniques has led to rapid expansion of the nanotheranostics field, allowing for more sensitive and specific diagnosis, real-time monitoring of drug delivery, and enhanced treatment efficacies across various malignancies.
The focus of this review is on the applications of nanotheranostics for HCC. The review first explores the current epidemiology and the commonly encountered obstacles in HCC diagnosis and treatment. It then presents the current technological and functional advancements in nanotheranostic technology for cancer in general, and then specifically explores the use of nanotheranostic modalities as a promising option to address the key challenges present in HCC management.
Keywords: Future therapy; Hepatic cancer; Hepatocellular carcinoma; Nanoplatform; Nanotheranostic; Personalized medicine.

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer

LAG3 is the most promising immune checkpoint next to PD-1 and CTLA-4. High LAG3 and FGL1 expression boosts tumor growth by inhibiting the immune microenvironment. This review comprises four sections presenting the structure/expression, interaction, biological effects, and clinical application of LAG3/FGL1. D1 and D2 of LAG3 and FD of FGL1 are the LAG3-FGL1 interaction domains. LAG3 accumulates on the surface of lymphocytes in various tumors, but is also found in the cytoplasm in non-small cell lung cancer (NSCLC) cells.

FGL1 is found in the cytoplasm in NSCLC cells and on the surface of breast cancer cells. The LAG3-FGL1 interaction mechanism remains unclear, and the intracellular signals require elucidation. LAG3/FGL1 activity is associated with immune cell infiltration, proliferation, and secretion.

Cytokine production is enhanced when LAG3/FGL1 are co-expressed with PD-1. IMP321 and relatlimab are promising monoclonal antibodies targeting LAG3 in melanoma. The clinical use of anti-FGL1 antibodies has not been reported. Finally, high FGL1 and LAG3 expression induces EGFR-TKI and gefitinib resistance, and anti-PD-1 therapy resistance, respectively. We present a comprehensive overview of the role of LAG3/FGL1 in cancer, suggesting novel anti-tumor therapy strategies.

Futility in Transcatheter Aortic Valve Implantation: A Search for Clarity

Although transcatheter aortic valve implantation (TAVI) has revolutionised the landscape of treatment for aortic stenosis, there exists a cohort of patients where TAVI is deemed futile. Among the pivotal high-risk trials, one-third to half of patients either died or received no symptomatic benefit from the procedure at 1 year.

Futility of TAVI results in the unnecessary exposure of risk for patients and inefficient resource utilisation for healthcare services. Several cardiac and extra-cardiac conditions and frailty increase the risk of mortality despite TAVI. Among the survivors, these comorbidities can inhibit improvements in symptoms and quality of life. However, certain conditions are reversible with TAVI (e.g. functional mitral regurgitation), attenuating the risk and improving outcomes.

Quantification of disease severity, identification of reversible factors and a systematic evaluation of frailty can substantially improve risk stratification and outcomes. This review examines the contribution of pre-existing comorbidities towards futility in TAVI and suggests a systematic approach to guide patient evaluation.

A practical method for storage, preservation and transportation of anuran urine samples using filter paper for hormone analysis

Anurans (frogs and toads) expelled urine when handled and it could provide insights into their physiological status. However, storage, preservation and transportation are often challenging. The study aimed to standardize and validate a field method for short-term storage and preserve of anuran urine samples using Whatman filter papers. To examine the efficacy of storage conditions and type of papers, urinary based enzyme immunoassays were used to measure progesterone and testosterone hormone metabolites.
  • High-Performance Liquid Chromatography was performed and revealed immunoreactive progesterone and testosterone metabolites in the urine samples.
  • Urinary hormone metabolites concentration stored in filter paper at room temperature and control samples stored in -20°C for the same period were similar. 
  • Whatman grade 50 was found to be more suitable for storage of hormones than grade 3 paper for the experiments performed.
  • A cheap and simple storage method for storage of anuran urine in field conditions using filter papers.
  • Anuran urine could be preserved and transported under ambient conditions without significant changes and loss of hormones.
  • This method would facilitate the endocrine monitoring of anurans in remote areas where limited logistics are available.

Whatman ReZist Filter 0.2µm

FIL2496 Scientific Laboratory Supplies PK100 277.02 EUR

Whatman ReZist Filter 0.45µm

FIL2498 Scientific Laboratory Supplies PK100 277.02 EUR

Whatman Syringe Filter Puradisc

67472502 Scientific Laboratory Supplies EACH 503.88 EUR

Whatman Syringe Filter 0.45um

6789-0404 Scientific Laboratory Supplies PK100 166.44 EUR

Whatman 10mm PE Filter

230300 Scientific Laboratory Supplies PK100 63.84 EUR

Whatman Filter Holder 13mm

420100 Scientific Laboratory Supplies PK10 93.48 EUR

Whatman 240mm Filter Circle

1114-240 Scientific Laboratory Supplies PK100 41.04 EUR

Filter Paper Whatman G1 580x680

FIL2044 Scientific Laboratory Supplies PK100 224.58 EUR

Whatman No2 47mm Filter Paper

FIL2051 Scientific Laboratory Supplies PK100 10.26 EUR

Whatman No3 240mm Filter Paper

FIL2079 Scientific Laboratory Supplies PK100 104.88 EUR

Whatman filter paper G52 125MM

FIL2261 Scientific Laboratory Supplies EACH 47.88 EUR

Whatman CN 47mm .45Ám Filter

FIL3078S Scientific Laboratory Supplies PK1000 858.42 EUR

Whatman Filter Holder 25mmx25ml Glass

FIL3200 Scientific Laboratory Supplies EACH 343.14 EUR

Whatman Filter Holder 25mmx50ml Glass

FIL3202 Scientific Laboratory Supplies EACH 459.42 EUR

Whatman Filter Holder 25mm SSteel

FIL3204 Scientific Laboratory Supplies EACH 425.22 EUR

Whatman Filter Holder 47mmx300ml Glass

FIL3206 Scientific Laboratory Supplies EACH 451.44 EUR

Whatman Filter Holder 47mmx300ml SSteel

FIL3208 Scientific Laboratory Supplies EACH 481.08 EUR

Whatman Vacu Guard PTFE Filter

FIL5170 Scientific Laboratory Supplies PK10 178.98 EUR

Whatman PolyVENT 1000 Capsule Filter

FIL5208 Scientific Laboratory Supplies EACH 116.28 EUR

Whatman Polycap TC150 0.2UM Filter

6704-9502 Scientific Laboratory Supplies PK5 647.52 EUR

Whatman puradisc 25 syringe filter

6747-2504 Scientific Laboratory Supplies PK200 503.88 EUR

Whatman CN Filter 3um 25mm

7193002 Scientific Laboratory Supplies PK100 139.08 EUR

Whatman 142mm GF/F Filter

1825142 Scientific Laboratory Supplies PK25 150.48 EUR

Whatman Filter Pads Grade 181

2181-090 Scientific Laboratory Supplies PK100 25.08 EUR

Whatman MiniUniprep Filter 0.2um PVDF

CHR2050 Scientific Laboratory Supplies PK100 229.14 EUR

Whatman MiniUniprep Filter 0.2um Nylon

CHR2052 Scientific Laboratory Supplies PK100 229.14 EUR
×

 

Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic, Moral outrage in COVID19- Understandable but not a strategy Tags:enzyme activity, enzyme and microbial technology, enzyme biosensor, enzyme cleaner, enzyme crypto, enzyme definition, enzyme definition biology, enzyme denaturation, enzyme diane, enzyme drain cleaner, enzyme finder, enzyme inhibition, enzyme kinetics, enzyme km, enzyme pdf, enzyme pectinase, enzyme solution, enzyme specificity, enzyme substrate complex, enzyme video, enzyme wiki, enzymedica, enzymes function, enzymes supplements

Post navigation

Previous Post: Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
Next Post: Estimation of salivary proteins in early childhood caries before and after treatment using gel electrophoresis

Related Posts

Moral outrage in COVID19- Understandable but not a strategy Moral outrage in COVID19- Understandable but not a strategy Moral outrage in COVID19- Understandable but not a strategy
Weather and Aggressive Behavior among Patients in Psychiatric Hospitals-An Exploratory Study Moral outrage in COVID19- Understandable but not a strategy
Comb coherence-transfer and cavity ring-down saturation spectroscopy around 1.65 μm: kHz-accurate frequencies of transitions in the 2ν 3 band of 12 CH 4 Moral outrage in COVID19- Understandable but not a strategy
Nocturnal incubation recess and flushing behavior by duck hens Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
Indirect signal amplification strategy with a universal probe-based lateral flow immunoassay for the rapid quantitative detection of fumonisin B1 Moral outrage in COVID19- Understandable but not a strategy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RSS Biology News Net

  • The proteins that domesticated our genomes
  • Study reveals how ionising radiation damages DNA and causes cancer
  • Human kidney progenitors isolated, offering new clues to cell renewal
  • Giraffes more speciose than expected
  • New 'Trojan horse' antibody strategy shows promise against all Ebola viruses
  • Brain circuit that drives sleep-wake states, sleep-preparation behavior is identified
  • New genus of bacteria found living inside hydraulic fracturing wells
  • Biochemists' discovery could lead to vaccine against 'flesh-eating' bacteria
  • More tomatoes, faster: Accelerating tomato engineering
  • New species of pterosaur discovered in Patagonia

February 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728  
« Dec    

Recent Posts

  • Compare ELISA lab reagents for research
  • Compare monoclonal lab reagents for research
  • TEST Lab Reagents for Research
  • Weather and Aggressive Behavior among Patients in Psychiatric Hospitals-An Exploratory Study
  • Nocturnal incubation recess and flushing behavior by duck hens

Recent Comments

    Copyright © 2023 Fao Ectad Bamako.

    Powered by PressBook Grid Blogs theme